 Calu-3(ICGECalu-3,IC-39666)
  Calu-3(ICGECalu-3,IC-39666)


Overview
        | Permits and Restrictions | |
|---|---|
| Organism | Homo sapiens, human | 
| Tissue | lung adenocarcinoma; derived from metastatic site: pleural effusion | 
| Cell Type | Epithelial cell | 
| Product Format | frozen | 
| Morphology | epithelial | 
| Culture Properties | adherent | 
| Biosafety Level | 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. | 
| Disease | adenocarcinoma | 
| Age | 25 years | 
| Gender | male | 
| Ethnicity | Caucasian | 
| Applications | 
					This cell line is a suitable transfection host.
				 | 
| Storage Conditions | liquid nitrogen vapor phase | 
Properties
        | Karyotype | The stemline chromosome number is hypotriploid with the 2S component occurring at 1.4%. Approximately 20 markers were common to most S metaphases, of which i (1p), t(12;?) and t(18;?) were generally paired; t(6t?) had an HSR segment of q arm, and M7 had two secondary constrictions. Normal chromosomes 1, 13, 15 and 17 were absent, and the X was disomic. No Y chromosome was detected in the QM stained preparations. Note: Cytogenetic information is based on initial seed stock at ATCC. Cytogenetic instability has been reported in the literature for some cell lines. | 
|---|---|
|  |  | 
| Clinical Data | 
					25 years
				 
					Caucasian
				 
					male
				 
					The patient had received prior therapy with cytoxan, bleomycin and adriamycin.
				 | 
| Antigen Expression | 
					Antigen expression: Blood Type A; Rh+
				 | 
| Genes Expressed | 
					Blood Type A; Rh+
				 | 
| Tumorigenic | Yes | 
| Effects | 
					Yes, forms well differentiated grade I adenocarcinoma in nude mice
				 | 
| Comments | 
					The patient had received prior therapy with cytoxan, bleomycin and adriamycin.
				 | 
Background
        | Complete Growth Medium | The base medium for this cell line is ATCC-formulated Eagle''''''''s Minimum Essential Medium, Catalog No. 30-2003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. | 
|---|---|
| Subculturing | 
 
					Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:6 is recommended
				 
					Medium Renewal: 2 to 3 times per week
				 | 
| Cryopreservation | 
					Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
				 
					Storage temperature: liquid nitrogen vapor phase
				 | 
| Culture Conditions | 
					Atmosphere: air, 95%; carbon dioxide (CO2), 5%
				 
					Temperature: 37¡ãC
				 | 








